M/10/046 – Aesica / UCB SA
Transaction details
The Competition Authority has cleared the proposed acquisition by Aesica Pharmaceuticals Limited of certain assets from UCB SA.
| Notification date | Decision date |
|---|---|
| Monday December 20, 2010 | Tuesday, January 11, 2011 |
| Parties Involved | Business activities |
|---|---|
| Aesica Pharmaceuticals Limited | Aesica provides pharmaceutical contract manufacturing services to customers located around the world including a number of customers located in Ireland. |
| UCB SA | The target assets of UCB SA are active in the contract manufacturing of pharmaceuticals, including packaging and warehousing/distribution services. |
| Economic sector | Media merger |
|---|---|
| The pharmaceuticals sector | No |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Friday, December 31, 2010 | |
| Current status: Completed |
|---|
| Cleared (Phase 1) |
| Authorised Officer Assigned | Contact Details |
|---|---|
| Mr. Andrew Rae | Tel: 01-804 5420, email: ar@tca.ie |
Media enquiries: MKC Communications: 01 7038600
Haven’t found what you’re looking for?
Scroll
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555